Product Program year 2020 Source: CMS Open Payments

N/A

Device Cancer Diagnostics

Open in the dashboard

General payments

$317,410

1,230 payments

Research payments

$22,613

2 payments

Through program year 2020, $317,410 in general payments and $22,613 in research payments were reported against N/A (Cancer Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $175,694 913
2019 General $141,716 317
2019 Research $22,613 2

Breakdown

Who paid General payments · program years 2019–2020
  1. Leica Microsystems Inc. $317,410 1,230 payments
Top recipients General payments · program year 2020
  1. New York Presbyterian Hospital Teaching hospital · NY $12,596 7% · 28 payments
  2. University Medical Center Of El Paso Teaching hospital · TX $9,753 6% · 26 payments
  3. Massachusetts General Hospital Teaching hospital · MA $7,508 4% · 34 payments
  4. Princeton Healthcare System Teaching hospital · NJ $7,349 4% · 10 payments
  5. Medical University Of South Carolina Teaching hospital · SC $6,614 4% · 40 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Surgery $1,422 66% · 44 practitioners
  2. Diagnostic Radiology Radiology $382 18% · 14 practitioners
  3. Vascular Surgery Surgery $120 6% · 1 practitioner
  4. Trauma Surgery Surgery $100 5% · 1 practitioner
  5. Surgical Oncology Surgery $67 3% · 3 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. New York $23,094 13% · 19 recipients
  2. Texas $16,297 9% · 20 recipients
  3. New Jersey $15,303 9% · 10 recipients
  4. North Carolina $12,510 7% · 7 recipients
  5. California $12,008 7% · 25 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,230 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record